<?xml version="1.0" encoding="UTF-8"?>
<fig id="Fig7">
 <label>Fig. 7</label>
 <caption>
  <p>The binding model of repurposed drugs against SARS-CoV-2 3CL
   <sup>pro</sup>. 
   <bold>a</bold> Binding mode of the Amentaflavone drug (red) in SARS-CoV-2 3CL
   <sup>pro</sup> (green) substrate binding pocket. 
   <bold>b</bold> Artemisinin drug (blue) binding mode in SARS-CoV-2 3CL
   <sup>pro</sup> (pink) substrate binding pocket. 
   <bold>c</bold> Binding mode of the Ritonavir drug (magenta) in SARS-CoV-2 3CL
   <sup>pro</sup> (cyan) substrate binding pocket. 
   <bold>d</bold> Binding mode of the Vitamin D (green) in SARS-CoV-2 3CL
   <sup>pro</sup> (red) substrate binding pocket. Protein–ligand interaction (hydrogen bond) are shown with red dotted lines
  </p>
 </caption>
 <graphic xlink:href="12967_2020_2448_Fig7_HTML" id="MO7" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
